Trial Details
COMPLETEDBasic Information
| Clinical ID | c2656 |
|---|---|
| Identifier | NCT03154086 |
| Trial Title | A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | DRUG: GSK3352589|DRUG: Matching Placebo |
Participant Information
| Sponsor | GlaxoSmithKline |
|---|---|
| City | South Australia |
| Country/Region | Australia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2017-05-17 |
|---|---|
| Primary Completion Date | 2018-03-05 |
| Completion Date | 2018-03-05 |